Clinical and neuropsychological profiles of obsessive-compulsive schizophrenia: A pilot study

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 12, Issue 1, 2000, Pages 91-94

  Hwang, Michael Y ^a   Morgan, Joel E ^b   Losconzcy, Miklos F ^b  

^a VA Medical Center New Jersey   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; LITHIUM CARBONATE; NEUROLEPTIC AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HOSPITALIZATION; HUMAN; MALE; NEUROPSYCHOLOGY; OBSESSION; PATHOPHYSIOLOGY; PILOT STUDY; PRIORITY JOURNAL; SCHIZOPHRENIA; SYMPTOM;

EID: 0033973358     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.12.1.91     Document Type: Article

References (30)

1. Westphal K: Über Zwangsvorstellungen. Archiv für Psychiatr und Nervenkr 1878; 8:734-750
2. Bleuler E: Dementia Praecox and Paraphrenia. Edinburg, Livingstone, 1919
3. Rosen I: The clinical significance of obsessions in schizophrenia. J Ment Sci 1957; 103:778-785
4. Karno M, Golding JM, Sorenson SB, et al: The epidemiology of obsessive-compulsive symptoms in schizophrenia. Am J Psychiatry 1988; 45:1094-1099
5. Fenton WS, McGlashan TH: The prognostic significance of obsessive-compulsive symptoms in schizophrenia. Am J Psychiatry 1986; 143:437-441
6. Eisen JL, Beer DA, Pato MT, et al: Obsessive-compulsive disorder in patients with schizophrenia or schizoaffective disorder. Am J Psychiatry 1997; 154:271-273
7. Hwang MY, Bermanzohn PC, Opler LA: Schizophrenia with obsessive-compulsive symptoms, in Management of Comorbid Conditions in Schizophrenia, edited by Hwang MY, Bermanzohn PC. Washington, DC, American Psychiatric Press (in press)
8. Hollander E: Obsessive-Compulsive Related Disorders. Washington, DC, American Psychiatric Press, 1993
9. Hwang MY, Rho J, Opler LA, et al: Treatment of an obsessive-compulsive schizophrenic patient with clomipramine: clinical and neuropsychological findings (letter). Neuropsychiatry Neuropsychol Behav Neurol 1995; 8:3:231-233
10. Stroebel CF, Szarek BL: Use of clomipramine in treatment of obsessive compulsive symptomatology. J Clin Psychopharmacol 1984; 4:98-100
11. Hwang MY, Opler LA: Schizophrenia with obsessive-compulsive features: assessment and treatment. Psychiatric Annals 1994; 24:468-172
12. Zohar J, Kaplan Z, Benjamin J: Clomipramine treatment of obsessive compulsive symptomatology in schizophrenic patients. J Clin Psychiatry 1993; 54:385-388
13. Berman I, Sapers BL, Chang HHJ, et al: Treatment of obsessive-compulsive symptoms in schizophrenic patients with clomipramine. J Clin Psychopharmacol 1995; 15:206-210
14. Nemeroff CB, DeVane L, Pollock BG: Newer antidepressants and the cytochrome P450 system. Am J Psychiatry 1996; 153:311-320
15. Spitzer RL, Williams JBW, Gibbon M, et al: Structured Clinical Interview for DSM-III-R-Patient Version (SCID-P). New York, Biometric Research Department, New York State Psychiatric Institute, 1988
16. Honigfeld G, Gillis R, Klett CJ: NOSIE-30: A treatment sensitive ward behavior scale. Psychol Rep 1966; 19:180-182
17. Strauss JS, Carpenter WT: The prediction of outcome in schizophrenia, II: relationships between predictors and outcome variables. Arch Gen Psychiatry 1974; 31:37-42
18. Kay SR, Fiszbein A, Opler LA: The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 1987; 13:261-276
19. Goodman WK, Price LH, Rasmussen SA, et al: The Yale-Brown Obsessive-Compulsive Scale (Y-BOCS), I: development, use, and reliability. Arch Gen Psychiatry 1989; 46:1006-1011
20. Quitkin F, Rifkin A, Klein DF: Neurologic soft signs in schizophrenia and character disorders. Arch Gen Psychiatry 1976; 33:845-853
21. National Institute of Mental Health Abnormal Involuntary Movements Scale (AIMS). Washington, DC, US Department of Health, Education, and Welfare, 1974
22. Heaton RK: A Manual for the Wisconsin Card Sorting Test. Odessa, FL, Psychological Assessment Resources, 1981
23. Folstein MF, Folstein SE, McHugh PR: "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198
24. Merriam A, Kay SR, Opler LA, et al: Neurological signs and positive-negative dimensions in schizophrenia. Biol Psychiatry 1990; 28:181-192
25. Opler LA, Ramirez PM, Rosenkilde CE, et al: Neurocognitive features of chronic schizophrenic patients. J Nerv Ment Dis 1991; 179:638-640
26. Butler RW, Jenkins MA, Sprock J, et al: Wisconsin Card Sorting Test deficits in chronic paranoid schizophrenia. Schizophr Res 1992; 7:169-176
27. Baxter LR: PET studies of cerebral function in major depression and obsessive-compulsive disorder: the emerging prefrontal cortex consensus. Ann Clin Psychiatry 1991; 3:103-109
28. Weinberger DR, Berman KF, Zec RF: Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia, I: regional cerebral blood flow evidence. Arch Gen Psychiatry 1986; 43:114-124
29. Baker RW, Bermanzohn PC, Wirshing DA, et al: Obsessions, compulsions, clozapine, and risperidone. CNS Spectrum 1997; 2:26-31
30. Hwang MY, Bermanzohn PC: Management of Comorbid Conditions in Schizophrenia. Washington, DC, American Psychiatric Press (in press)